The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,500.00
Bid: 5,495.00
Ask: 5,505.00
Change: 25.00 (0.46%)
Spread: 10.00 (0.182%)
Open: 5,505.00
High: 5,540.00
Low: 5,490.00
Prev. Close: 5,475.00
DCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

7 Feb 2018 07:00

RNS Number : 1135E
DCC PLC
07 February 2018
 

 

7 February 2018

 

DCC plc

 

Interim Management Statement

 

Trading in line with expectations and DCC Healthcare acquisition in US

 

DCC plc, the leading international sales, marketing and support services group, is issuing this Interim Management Statement for the third quarter ended 31 December 2017.

 

Third quarter ended 31 December 2017

Group operating profit for the third quarter ended 31 December 2017 was in line with expectations and ahead of the prior year.

 

Operating profit in DCC LPG was in line with expectations and the prior year, despite the headwind of an increasing cost of product. The mild weather conditions experienced early in the quarter impacted heating-related volumes modestly, although this was largely offset by good cost control. As previously announced, the French business launched its consumer natural gas and electricity initiative during the quarter and continues to invest in the development of its offering.

 

DCC Retail & Oil recorded good growth in operating profit, driven by strong organic profit growth in Denmark and Fuel Card. The business in Britain performed in line with expectations.

 

DCC Healthcare recorded strong growth in operating profit. DCC Vital delivered good organic profit growth, particularly in medical devices, and also benefited from the acquisition of Medisource completed during the prior year. DCC Health & Beauty Solutions again delivered strong growth in nutritional products.

 

Operating profit in DCC Technology was ahead of the prior year, benefiting from acquisitions and a good organic performance from the UK and Ireland, DCC Technology's largest business, where strong growth was achieved in the key product areas of audio visual, smart home and enterprise. The French consumer products business remains challenging and a number of operational changes are underway to improve performance. The remaining Continental European businesses continued to perform well and traded in line with expectations.

 

Year to 31 March 2018

Notwithstanding the mild start to the fourth quarter, particularly in France, DCC expects that both operating profit and adjusted earnings per share will be well ahead of the prior year and in line with current market consensus.

Development activity

The year to date has been very active from a development perspective. Reflecting the announced acquisition activity, the Group's cash spend on acquisitions in the current financial year will be approximately £670 million.

 

Today's announcement by DCC Healthcare of the acquisition of Elite One Source Nutritional Services, Inc ("Elite") is an exciting step in the expansion of DCC Health & Beauty Solutions. The acquisition is the business' first step into the growing US market, the world's leading healthcare and dietary supplements market. Based in Missoula, Montana, Elite is a provider of contract manufacturing and related services to leading specialist brands in the US consumer healthcare market. The business, led by an experienced management team, employs 180 people and operates from well-invested facilities which comply with FDA cGMP and Health Canada standards and are certified by leading third party regulatory bodies. The consideration, based on an enterprise value of $50 million (£35 million), was paid in cash on completion. Elite is expected to generate a return on capital employed of approximately 15% within the first two years of ownership.

 

The completion processes for the previously announced acquisitions of Retail West, TEGA and Countrywide are progressing to plan and all transactions are expected to complete by the end of the current financial year.

 

DCC remains ambitious to continue the growth and development of its business in existing and new geographies and retains a strong, well-funded and liquid balance sheet.

 

Final results

DCC expects to announce its results for the year to 31 March 2018 on 15 May 2018.

 

 

For reference:

Donal Murphy, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Capital Markets

 

Telephone: +353 1 2799400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

Powerscourt (Media)

Lisa Kavanagh / Victoria Palmer-Moore

 

Telephone: +44 20 7250 1446

Email: DCC@powerscourtgroup.com

 

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology.

 

DCC is an ambitious and entrepreneurial business operating in 15 countries, supplying products and services used by millions of people every day throughout Europe. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

 

Headquartered in Dublin, employing approximately 10,000 people, DCC’s four divisions are:
· DCC LPG - a leading LPG sales and marketing business with operations in Europe and Asia and a developing business in the retailing of natural gas and electricity;
· DCC Retail & Oil - a leader in the sales, marketing and retailing of transport fuels and commercial fuels, heating oils and related products and services in Europe;
· DCC Healthcare - a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners; and
· DCC Technology - a leading European sales, marketing and services partner for global technology brands. 

DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2017, DCC generated revenue of £12.3 billion and operating profit of £345 million.

 

DCC has an excellent record, delivering compound annual growth of 14% in operating profit and generating an average return on capital employed of approximately 19% over 23 years as a public company.

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDQLFBVLFEBBE
Date   Source Headline
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1
25th Sep 20195:39 pmRNSHolding in Company TR-1
4th Sep 20199:57 amRNSHolding in Company TR-1
9th Aug 201910:42 amRNSHolding in Company TR-1
7th Aug 20199:23 amRNSHolding in Company TR-1
31st Jul 20192:58 pmRNSTotal Voting Rights
16th Jul 20196:14 pmRNSDirector/PDMR Shareholding
12th Jul 20193:06 pmRNSResult of AGM
12th Jul 20197:00 amRNSInterim Management Statement
5th Jul 20199:06 amRNSHolding in Company TR-1
19th Jun 20199:22 amRNSHolding in Company TR-1
13th Jun 201911:37 amRNS2019 Annual Report, Notice of AGM and Proxy Form
31st May 20199:47 amRNSTotal Voting Rights
28th May 20197:00 amRNSHolding in Company TR-1
23rd May 20196:25 pmRNSDirector/PDMR Shareholding
22nd May 20199:43 amRNSHolding in Company TR-1
16th May 20199:03 amRNSHolding in Company TR-1
14th May 20197:01 amRNSDCC Development Update
14th May 20197:00 amRNSResults for the year ended 31 March 2019
13th May 201910:14 amRNSBoard Change
28th Mar 20198:47 amRNSDirector Declaration
28th Feb 20199:00 amRNSTotal Voting Rights
5th Feb 20197:00 amRNSInterim Management Statement
1st Feb 20194:25 pmRNSHolding in Company TR-1
25th Jan 20193:12 pmRNSHolding in Company TR-1
22nd Jan 20192:27 pmRNSHolding in Company TR-1
10th Jan 201912:58 pmRNSHolding in Company TR-1
2nd Jan 20193:07 pmRNSHolding in Company TR-1
14th Dec 201811:50 amRNSHolding in Company TR-1
12th Dec 20189:08 amRNSHolding in Company TR-1
30th Nov 20183:03 pmRNSTotal Voting Rights
29th Nov 20184:50 pmRNSHolding in Company TR-1
19th Nov 20186:01 pmRNSHolding in Company TR-1
19th Nov 20185:59 pmRNSDirector/PDMR Shareholding
19th Nov 20182:27 pmRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
6th Nov 20185:45 pmRNSHolding in Company TR-1
31st Oct 20183:26 pmRNSTotal Voting Rights
30th Oct 20189:51 amRNSBoard Resignation
24th Oct 20185:58 pmRNSHolding in Company TR-1
2nd Oct 20185:37 pmRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.